Item 2. Unregistered Sales of Equity Securities
Item 2. Unregistered Sales of Equity Securities
and Use of Proceeds.
During the first quarter of 2023, the Company
sold the following unregistered equity securities, which have not been previously been reported in its Annual Report on Form 10-K for
the year ended December 31, 2022 or in a Current Report on form 8-K:
On Feb 1, 2023, the Company issued 5,000 shares
of our common stock to our then Chief Medical Officer per his service agreement dated September 15, 2020.
During the first quarter of 2023 the Company issued
a total of 670,000 shares of our common stock to five “ accredited investors” at a price per share ranging from $0.25
to $0.40 resulting in proceeds of $189,500 to the Company.
On March 4, 2023, the Company issued 6,600 shares
to a vendor for consulting services.
The above securities were issued pursuant to the
exemptions from registration of Section 4(a)(2) of the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not applicable.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.